SYNERGISTIC ANTITUMOR EFFECT OF ASCORBIC ACID, LYSINE, PROLINE, AND EPIGALLOCATECHIN GALLATE ON HUMAN FIBROSARCOMA CELLS HT-1080
Annals of Cancer Research and Therapy · 2004
DOI: 10.4993/acrt.12.146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Cancer Research and Therapy, 2004. Verfasst von M. Waheed Roomi und 3 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Roomi, M. W., Ivanov, V., Niedzwiecki, A., & Rath, M. (2004). SYNERGISTIC ANTITUMOR EFFECT OF ASCORBIC ACID, LYSINE, PROLINE, AND EPIGALLOCATECHIN GALLATE ON HUMAN FIBROSARCOMA CELLS HT-1080. Annals of Cancer Research and Therapy. https://doi.org/10.4993/acrt.12.146
Vancouver
Roomi MW, Ivanov V, Niedzwiecki A, Rath M. SYNERGISTIC ANTITUMOR EFFECT OF ASCORBIC ACID, LYSINE, PROLINE, AND EPIGALLOCATECHIN GALLATE ON HUMAN FIBROSARCOMA CELLS HT-1080. Annals of Cancer Research and Therapy. 2004. doi:10.4993/acrt.12.146
BibTeX
@article{Roomi2004,
author = {Roomi, M. Waheed and Ivanov, Vadim and Niedzwiecki, Aleksandra and Rath, Matthias},
title = {SYNERGISTIC ANTITUMOR EFFECT OF ASCORBIC ACID, LYSINE, PROLINE, AND EPIGALLOCATECHIN GALLATE ON HUMAN FIBROSARCOMA CELLS HT-1080},
journal = {Annals of Cancer Research and Therapy},
year = {2004},
doi = {10.4993/acrt.12.146}
}
EUVIMED